Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Cited by (1,005)

Items 301–400 of 1,005

1. Alzheimer disease pathology as a host response
   Castellani, Rudy J., Lee, Hyoung-gon, Zhu, Xiongwei, Perry, George, Smith, Mark A. · 2008 · Journal of Neuropathology & Experimental Neurology
2. Inhibition of cathepsin B reduces β-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate β-secretase of Alzheimer's disease
   VIVIAN Y. H. HOOK, Thomas Toneff, Matthew S. Bogyo, Doron C. Greenbaum, Katalin F. Medzihradszky, John M. Neveu, William S. Lane, Gregory Hook, Terry Reisine · 2005 · Biological Chemistry
3. Mitofusin‐2 knockdown increases ER –mitochondria contact and decreases amyloid β‐peptide production
   Nuno Santos Leal, Bernadette Schreiner, Catarina Moreira Pinho, Riccardo Filadi, Birgitta Wiehager, Helena Karlström, Paola Pizzo, Maria Ankarcrona · 2016 · Journal of Cellular and Molecular Medicine
4. Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons
   Karine Laulagnier, Charlotte Javalet, Fiona J. Hemming, Mathilde Chivet, Gaelle Moisand Lachenal, Béatrice Blot, Christine Chatellard, Rémy Sadoul · 2017 · Cellular and Molecular Life Sciences
5. Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide
   Ira Espuny-Camacho, Lutgarde Serneels, Kurt Spittaels, Pascal Merchiers, Diana Ines Dominguez, Bart De Strooper · 2004 · Journal of Neuroscience
6. Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease
   Harry V. Vinters, Zhen Zhen Wang, Diana Lenard Secor · 1996 · Brain Pathology
7. Epigenetic Alterations in Alzheimer’s Disease
   Jose Vicente Sanchez-Mut, Johannes Gräff · 2015 · Frontiers in Behavioral Neuroscience
8. The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
   Storey, Roberto Cappai · 1999 · Neuropathology and Applied Neurobiology
9. Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
   Martin C. Herzig, William E. Van Nostrand, Mathias Jucker · 2006 · Brain Pathology
10. The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
    Santa Mammana, Paolo Fagone, Eugenio Cavalli, Maria Sofia Basile, Maria Cristina Petralia, Ferdinando Nicoletti, Placido Bramanti, Emanuela Mazzon · 2018 · International Journal of Molecular Sciences
11. Identification of the phenotype in psychiatric genetics
    Ming T. Tsuang, Stephen V. Faraone, Michael J. Lyons · 1993 · European Archives of Psychiatry and Clinical Neuroscience
12. Alzheimer's disease and acetylcholine receptors
    Takeshi Kihara, Shun Shimohama · 2004 · Acta Neurobiologiae Experimentalis
13. Alternative, Non-secretase Processing of Alzheimer's β-Amyloid Precursor Protein during Apoptosis by Caspase-6 and -8
    Luca Pellegrini, Brent J. Passer, Massimo Tabaton, J. Kelly Ganjei, Luciano D'adamio · 1999 · Journal of Biological Chemistry
14. Calcium and Neuronal Injury in Alzheimer's Disease
    Mark P. Mattson · 1994 · Annals of the New York Academy of Sciences
15. The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
    Ana Lloret, Daniel Esteve, Paloma Monllor, Ana Cervera‐Ferri, Ángeles Lloret · 2019 · International Journal of Molecular Sciences
16. Amyloids and Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation
    Turner, R. Scott, Suzuki, Nobuhiro, Chyung, Abraham S.C., Younkin, Steven G., Lee, Virginia M.-Y. · 1996 · Journal of Biological Chemistry
17. Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
    Boncristiano, Sonia, Calhoun, Michael E., Kelly, Peter H., Pfeifer, Michelle, Bondolfi, Luca, Stalder, Martina, Phinney, Amie L., Abramowski, Dorothee, Sturchler-Pierrat, Christine, Enz, Albert et al. · 2002 · The Journal of Neuroscience
18. Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice
    Fryer, John D., Taylor, Jennie W., DeMattos, Ronald B., Bales, Kelly R., Paul, Steven M., Parsadanian, Maia, Holtzman, David M. · 2003 · The Journal of Neuroscience
19. Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes.
    Anjun Chen, Pablo Engel, Thomas F. Tedder · 1995 · The Journal of Experimental Medicine
20. The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase Activities
    Hans‐Wolfgang Klafki, Dorothée Abramowski, Robert Swoboda, Paolo Paganetti, Matthias Staufenbiel · 1996 · Journal of Biological Chemistry
21. Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic Mice
    Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G. et al. · 1997 · Human Molecular Genetics
22. Nonfibrillar diffuse amyloid deposition due to a gamma42-secretase site mutation points to an essential role for N-truncated Abeta42 in Alzheimer's disease
    Kumar-Singh, S. · 2000 · Human Molecular Genetics
23. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile
    Alpaslan Dedeoglu, Ji‐Kyung Choi, Kerry Cormier, Neil W. Kowall, Bruce G. Jenkins · 2004 · Brain Research
24. Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.
    Suzanne Y. Guénette, J Chen, P. D. Jondro, Rudolph E. Tanzi · 1996 · Proceedings of the National Academy of Sciences
25. Recent advances in the modeling of Alzheimer’s disease
    Sasaguri, Hiroki, Hashimoto, Shoko, Watamura, Naoto, Sato, Kaori, Takamura, Risa, Nagata, Kenichi, Tsubuki, Satoshi, Ohshima, Toshio, Yoshiki, Atsushi, Sato, Kenya et al. · 2022 · Frontiers in Neuroscience
26. γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying Length
    Michael Paul Murphy, Lesley Hickman, Christopher B. Eckman, Sacha Uljon, Rong Wang, Todd Eliot Golde · 1999 · Journal of Biological Chemistry
27. BACE2, as a novel APP θ‐secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome
    Xiulian Sun, Guiqiong He, Weihong Song · 2006 · The FASEB Journal
28. Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis
    Andrea Claire LeBlanc · 1995 · Journal of Neuroscience
29. ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site
    Ishrut Hussain, David J. Powell, David R Howlett, Gayle A. Chapman, L. Gilmour, Paul R. Murdock, David G. Tew, Thomas D. Meek, Conrad G. Chapman, K. Schneider et al. · 2000 · Molecular and Cellular Neuroscience
30. Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
    Zhao, Wei-Qin, Lacor, Pascale N., Chen, Hui, Lambert, Mary P., Quon, Michael J., Krafft, Grant A., Klein, William L. · 2009 · Journal of Biological Chemistry
31. Amyloid β‐protein (Aβ)1–40 protects neurons from damage induced by Aβ1–42 in culture and in rat brain
    Kun Zou, Dae Sung Kim, Atsuko Kakio, Kyunghee Byun, Jian‐Sheng Gong, Jae Woo Kim, Myeung Ju Kim, Naoya Sawamura, Sei‐ichi Nishimoto, Katsumi Matsuzaki et al. · 2003 · Journal of Neurochemistry
32. The novel cargo Alcadein induces vesicle association of kinesin‐1 motor components and activates axonal transport
    Yoichi Araki, Takanori Kawano, Hidenori Taru, Yuhki Saito, Sachiyo Wada, Kanako Miyamoto, Hisako Kobayashi, Hiroyuki Ishikawa, Yu Ohsugi, Tohru Yamamoto et al. · 2007 · The EMBO Journal
33. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.
    Takami Tomiyama, Satoshi Asano, Yoshiko Furiya, Takuji Shirasawa, Noriaki Endo, Hiroshi Mori · 1994 · Journal of Biological Chemistry
34. Amyloid β protein in plasma from patients with sporadic Alzheimer's disease
    Akira Tamaoka, Tetsuo Fukushima, Naoya Sawamura, Kin'ya Ishikawa, Eiichi Oguni, Yasuko Komatsuzaki, Shin’ichi Shoji · 1996 · Journal of the Neurological Sciences
35. Dementia of the eye: the role of amyloid beta in retinal degeneration
    J. Arjuna Ratnayaka, Louise C. Serpell, Andrew John Lotery · 2015 · Eye
36. High selective expression of α7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques
    Wenfeng Yu, Zhi-Zhong Guan, Nenad Bogdanović, Agneta K. Nordberg · 2005 · Experimental Neurology
37. The Genetics of the Amyloidoses
    Joel N. Buxbaum, Clément E. Tagoe · 2000 · Annual Review of Medicine
38. Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
    Lars Lannfelt, Christer Möller, Hans Basun, Gunilla Osswald, Dag Sehlin, Andrew Satlin, Veronika Logovinsky, Pär Gellerfors · 2014 · Alzheimer s Research & Therapy
39. Secreted forms of β‐amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons
    Mark P. Mattson · 1994 · Journal of Neurobiology
40. Enhanced Amyloidogenic Processing of the β-Amyloid Precursor Protein in Gene-targeted Mice Bearing the Swedish Familial Alzheimer's Disease Mutations and a “Humanized” Aβ Sequence
    Reaume, Andrew G., Howland, David S., Trusko, Stephen P., Savage, Mary J., Lang, Diane M., Greenberg, Barry D., Siman, Robert, Scott, Richard W. · 1996 · Journal of Biological Chemistry
41. β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
    Brian D. Hitt, Sean M. Riordan, Lokesh Kukreja, William A. Eimer, Tharinda W. Rajapaksha, Robert J. Vassar · 2012 · Journal of Biological Chemistry
42. Evidence for an Alzheimer Disease Susceptibility Locus on Chromosome 12 and for Further Locus Heterogeneity
    Ekaterina A. Rogaeva · 1998 · JAMA
43. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
    Nishit Pathak, Sunil Kumar Vimal, Ishi Tandon, Lokesh Agrawal, Hongyi Cao, Sanjib Bhattacharyya · 2021 · Metabolic Brain Disease
44. Amyloid Precursor Protein and Notch Intracellular Domains are Generated after Transport of their Precursors to the Cell Surface
    Christoph Kaether, Stéphanie Schmitt, Michael Willem, Christian Haass · 2006 · Traffic
45. The γ-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl Ester Reduces Aβ Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice
    Thomas A. Lanz, Carol S. Himes, Giovanni Pallante, Lisa Adams, Shinji Yamazaki, Ben Amore, Kalpana Merchant · 2003 · Journal of Pharmacology and Experimental Therapeutics
46. Flemish and Dutch Mutations in Amyloid β Precursor Protein Have Different Effects on Amyloid β Secretion
    Chris De Jonghe, Cynthia Zehr, Debra Yager, Cristian-Mihail Prada, Steven G. Younkin, Lydia Hendriks, Christine Van Broeckhoven, Christopher B. Eckman · 1998 · Neurobiology of Disease
47. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch
    Anja Capell, Harald Steiner, Helmut Romig, Simone Keck, Miriam Baader, Melissa G. Grim, Ralf Baumeister, Christian Haass · 2000 · Nature Cell Biology
48. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease
    Reza M. Salek, Jing Xia, Amy E. Innes, Brian C. Sweatman, Róbert Adalbert, Suzanne J. Randle, Eileen M. McGowan, Piers C. Emson, Julian Leether Griffin · 2010 · Neurochemistry International
49. Secretase inhibitors and modulators for Alzheimer’s disease treatment
    Taisuke Tomita · 2009 · Expert Review of Neurotherapeutics
50. Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease
    Lisa N. Geller, Huntington Potter · 1999 · Neurobiology of Disease
51. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice
    Katrin Schüssel, S Schäfer, Thomas A. Bayer, Christian Czech, Laurent Pradier, Franz Müller-Spahn, Walter E. Müller, Anne Eckert · 2004 · Neurobiology of Disease
52. Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling
    Qosa, Hisham, Abuasal, Bilal S., Romero, Ignacio A., Weksler, Babette, Couraud, Pierre-Oliver, Keller, Jeffrey N., Kaddoumi, Amal · 2014 · Neuropharmacology
53. If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
    Haass, Christian, Selkoe, Dennis · 2022 · PLOS Biology
54. Genomics of Alzheimer Disease
    Roger N. Rosenberg, Doris Lambracht‐Washington, Gang Yu, Weiming Xia · 2016 · JAMA Neurology
55. Oxidative Stress Induces Increase in Intracellular Amyloid β-Protein Production and Selective Activation of βI and βII PKCs in NT2 Cells
    Dimitri Paola, Cinzia Domenicotti, Mariapaola Nitti, Antonella Vitali, Roberta Borghi, Damiano Cottalasso, D Zaccheo, Patrizio R. Odetti, Paola Strocchi, Umberto Maria Marinari et al. · 2000 · Biochemical and Biophysical Research Communications
56. Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
    Eliezer Masliah, Michael F. Alford, Margaret E. Mallory, Edward M. Rockenstein, Dieder Moechars, Fred VAN LEUVEN · 2000 · Experimental Neurology
57. Oral vaccination with a viral vector containing Aβ cDNA attenuates age‐related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model
    Akihiro Mouri, Yukihiro Noda, Hideo Hara, Hiroyuki Mizoguchi, Takeshi Tabira, Toshitaka Nabeshima · 2007 · The FASEB Journal
58. Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death
    Nathalie Pierrot, Philippe Ghisdal, Anne‐Sophie Caumont, Jean‐Noël Octave · 2004 · Journal of Neurochemistry
59. cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein
    Pari Malherbe, J. Grayson Richards, Hélène Gaillard, Annick Thompson, Catherine Diener, Angelika Schuler, Gerda Huber · 1999 · Molecular Brain Research
60. Basic FGF attenuates amyloid β-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons
    Mark, Robert J, Keller, Jeffrey N, Kruman, Inna, Mattson, Mark P · 1997 · Brain Research
61. Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches
    Cheryl Lea Wellington, Michael R. Hayden · 2000 · Clinical Genetics
62. Selective ectodomain phosphorylation and regulated cleavage of beta‐amyloid precursor protein.
    Albert Y. Hung, Dennis J. Selkoe · 1994 · The EMBO Journal
63. Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity
    Koon‐Ho Chan, Karen S.L. Lam, On-Yin Cheng, Jason Kwan, Philip Wing‐Lok Ho, Kenneth K.Y. Cheng, Sookja Kim Chung, Jessica Wing-Man Ho, Vivian Yawei Guo, Almin Xu · 2012 · PLoS ONE
64. Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation
    Janet A. Johnston, Richard F. Cowburn, Svante Norgren, Birgitta Wiehager, Nikolaos Venizelos, Bengt G. Winblad, Carmen Vigo‐Pelfrey, Dale Schenk, Lars Lannfelt, Cora O’Neill · 1994 · FEBS Letters
65. β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease
    Kelly Willemijn Menting, Jurgen A.H.R. Claassen · 2014 · Frontiers in Aging Neuroscience
66. Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
    Hyoung‐gon Lee, Xiongwei Zhu, Rudy J. Castellani, Akihiko Nunomura, George L. Perry, Mark A. Smith · 2007 · Journal of Pharmacology and Experimental Therapeutics
67. Alzheimer’s disease: a dysfunction of the amyloid precursor protein11Published on the World Wide Web on 11 September 2000.
    Rachael L. Neve, Donna L. McPhie, Yuzhi Chen · 2000 · Brain Research
68. Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases
    Hélène Barelli, Anthony Lebeau, Jean Vizzavona, Pia Delaère, Nathalie Chevallier, Cyrille Drouot, Philippe Marambaud, Karine Ancolio, Joseph D. Buxbaum, Olga Khorkova et al. · 1997 · Molecular Medicine
69. Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
    Akira Tamaoka, Naoya Sawamura, Tetsuo Fukushima, Shin’ichi Shoji, Etsuro Matsubara, Mikio Shoji, Shunsaku Hirai, Yoshiko Furiya, Riuko Endoh, Hiroshi Mori · 1997 · Journal of the Neurological Sciences
70. Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier
    Berislav V. Zloković · 1996 · Life Sciences
71. The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion‐like elements [PSI + ] and [PIN + ]
    Ping Zhou, Irina L. Derkatch, Susan Weiss Liebman · 2001 · Molecular Microbiology
72. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons
    Pentti J. Tienari, Nobuo Ida, Elina Ikonen, Mikael Simons, Andreas Weidemann, Gerd Multhaup, Colin Louis Masters, Carlos G. Dotti, Konrad T. Beyreuther · 1997 · Proceedings of the National Academy of Sciences
73. Twenty years of Alzheimer’s disease‐causing mutations
    Alison Goate, John Hardy · 2011 · Journal of Neurochemistry
74. Targeting the JAK2/STAT3 axis in Alzheimer's disease
    Tomohiro Chiba, Marina Yamada, Sadakazu Aiso · 2009 · Expert Opinion on Therapeutic Targets
75. Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
    Richard Lathe, Alexandra A. Tsitrina, Yuri V. Kotelevtsev · 2014 · BMC Geriatrics
76. Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology
    Korey Kam, Áine Duffy, Jillian N. Moretto, John J. LaFrancois, Helen E. Scharfman · 2016 · Scientific Reports
77. Novel β-Secretase Cleavage of β-Amyloid Precursor Protein in the Endoplasmic Reticulum/Intermediate Compartment of NT2N Cells
    Abraham S.C. Chyung, Barry Greenberg, David G. Cook, Robert W. Doms, Virginia M.‐Y. Lee · 1997 · The Journal of Cell Biology
78. X11 Interaction with β-Amyloid Precursor Protein Modulates Its Cellular Stabilization and Reduces Amyloid β-Protein Secretion
    Magdalena Sastre, Raymond Scott Turner, Efrat Levy · 1998 · Journal of Biological Chemistry
79. Inflammation occurs early during the Aβ deposition process in TgCRND8 mice
    Sherri Dudal, Pascale Krzywkowski, Julie Paquette, Céline Morissette, Diane Lacombe, Patrick Tremblay, Francine Gervais · 2004 · Neurobiology of Aging
80. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.
    Pedersen, W A, Kloczewiak, M A, Blusztajn, J K · 1996 · Proceedings of the National Academy of Sciences
81. Calorie restriction slows age-related microbiota changes in an Alzheimer’s disease model in female mice
    Laura M. Cox, Marissa J. Schafer, Jiho Sohn, Julia Vincentini, Howard L. Weiner, Stephen D. Ginsberg, Martin J. Blaser · 2019 · Scientific Reports
82. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease
    Susanne Hauptmann, Uta Keil, Isabel Scherping, Astrid Bonert, Anne Eckert, Walter E. Müller · 2006 · Experimental Gerontology
83. Making the final cut: Pathogenic amyloid-β peptide generation by γ-secretase
    Steiner, Harald, Fukumori, Akio, Tagami, Shinji, Okochi, Masayasu · 2018 · Cell Stress
84. Presenilin-1 P264L Knock-In Mutation: Differential Effects on Aβ Production, Amyloid Deposition, and Neuronal Vulnerability
    Siman, Robert, Reaume, Andrew G., Savage, Mary J., Trusko, Stephen, Lin, Yin-Guo, Scott, Richard W., Flood, Dorothy G. · 2000 · The Journal of Neuroscience
85. Pathophysiology of Alzheimer's Disease
    Bruno Pietro Imbimbo, Jay Lombard, Nunzio Pomara · 2005 · Neuroimaging Clinics of North America
86. Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
    Michela Guglielmotto · 2010 · Frontiers in Aging Neuroscience
87. Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential
    Michael S. Wolfe · 2001 · Journal of Medicinal Chemistry
88. AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
    Susanna Eketjäll, Juliette Janson, Karin Kaspersson, Anna Bogstedt, Fredrik Jeppsson, Johanna M. Fälting, Samantha Budd Haeberlein, Alan R. Kugler, Robert C. Alexander, Gvido Cebers · 2016 · Journal of Alzheimer s Disease
89. N -glycan and Alzheimer's disease
    Yasuhiko Kizuka, Shinobu Kitazume, Naoyuki Taniguchi · 2017 · Biochimica et Biophysica Acta (BBA) - General Subjects
90. The Role of Presenilins in γ-Secretase Activity
    Michael S. Wolfe, Christian Haass · 2001 · Journal of Biological Chemistry
91. CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
    Donald L. Price, Sangram S. Sisodia · 1994 · Annual Review of Medicine
92. The Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease
    Ruth MacLeod, Ellin‐Kristina Hillert, Ryan T. Cameron, George S. Baillie · 2015 · Future Science OA
93. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced <scp>AMPA</scp> glutamate receptor signaling deficits
    Miller, Eric C., Teravskis, Peter J., Dummer, Benjamin W., Zhao, Xiaohui, Huganir, Richard L., Liao, Dezhi · 2014 · European Journal of Neuroscience
94. Increased cerebrospinal fluid tau in patients with Alzheimer's disease
    Malene Jensen, Hans Basun, Lars Lannfelt · 1995 · Neuroscience Letters
95. FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction
    Flood, D · 2002 · Neurobiology of Aging
96. Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease¹
    Avramovich‐Tirosh, Yael, Amit, Tamar, Bar‐Am, Orit, Zheng, Hailin, Fridkin, Mati, Youdim, Moussa B. H. · 2007 · Journal of Neurochemistry
97. The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
    Robert J. Vassar, Patty C. Kandalepas · 2011 · Alzheimer s Research & Therapy
98. Dual Cleavage of Neuregulin 1 Type III by BACE1 and ADAM17 Liberates Its EGF-Like Domain and Allows Paracrine Signaling
    Daniel Fleck, Frauke van Bebber, Alessio Vittorio Colombo, Chiara Galante, Benjamin M. Schwenk, Linnéa Rabe, Heike Hampel, Božidar Novak, Elisabeth Kremmer, Sabina Tahirović et al. · 2013 · Journal of Neuroscience
99. Variations in the neuropathology of familial Alzheimer’s disease
    Claire E. Shepherd, Heather McCann, Glenda Margaret Halliday · 2009 · Acta Neuropathologica
100. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice
     Lamb, B. · 1997 · Human Molecular Genetics